Finance

Lists
NECLIFE:NSE
Nectar Lifesciences Ltd
10,10 INR
-0,49%
(-0,050) 1D
14 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NECLIFE...
Open
10,25 INR
High
10,35 INR
Low
10,05 INR
Mkt. cap
1,96 მლრდ.
Avg. vol.
163,74 ათ.
Volume
56,29 ათ.
52-wk high
22,40 INR
52-wk low
9,30 INR
EPS
-11,38 INR
Shares outstanding
224,26 მლნ.
No. of employees
111
Open
10,25 INR
High
10,35 INR
Low
10,05 INR
Mkt. cap
1,96 მლრდ.
Avg. vol.
163,74 ათ.
Volume
56,29 ათ.
52-wk high
22,40 INR
52-wk low
9,30 INR
EPS
-11,38 INR
Shares outstanding
224,26 მლნ.
No. of employees
111
News stories
From web sources and news partners
About Nectar Lifesciences Ltd
CEO-
Employees111
Founded1995
Headquartersჩანდიგარჰი, ჩანდიგარჰი, ინდოეთი
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
49,97 მლნ.
-
-
145,00 ათ.
Cost of goods sold
33,54 მლნ.
-
-
137,00 ათ.
Cost of revenue
33,54 მლნ.
-
-
137,00 ათ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,52 მლნ.
6,10 მლნ.
22,94 მლნ.
10,64 მლნ.
Operating expense
21,48 მლნ.
13,26 მლნ.
1,11 მლრდ.
244,63 მლნ.
Total operating expenses
55,03 მლნ.
13,26 მლნ.
1,11 მლრდ.
244,77 მლნ.
Operating income
-5,06 მლნ.
-13,26 მლნ.
-1,11 მლრდ.
-244,63 მლნ.
Other non operating income
-
-
2,40 მლნ.
-
EBT including unusual items
-5,06 მლნ.
566,01 მლნ.
-1,45 მლრდ.
-246,20 მლნ.
EBT excluding unusual items
-5,06 მლნ.
-315,50 მლნ.
-1,09 მლრდ.
-246,20 მლნ.
Income tax expense
-1,77 მლნ.
-110,25 მლნ.
-197,17 მლნ.
-89,01 მლნ.
Effective tax rate
34,95%
-19,48%
13,59%
36,15%
Other operating expenses
11,92 მლნ.
6,54 მლნ.
1,08 მლრდ.
232,89 მლნ.
Net income
-1,76 მლრდ.
142,70 მლნ.
-679,24 მლნ.
-153,98 მლნ.
Net profit margin
-3 522,51%
-
-
-106 191,03%
Earnings per share
-
-
-
-
Interest and investment income
-
-
371,18 მლნ.
-
Interest expense
-
-302,25 მლნ.
-
-1,57 მლნ.
Net interest expenses
-
-302,25 მლნ.
371,18 მლნ.
-1,57 მლნ.
Depreciation and amortization charges
2,04 მლნ.
619,00 ათ.
832,00 ათ.
1,11 მლნ.
EBITDA
104,86 მლნ.
142,71 მლნ.
-1,05 მლრდ.
-187,62 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები